Publications in collaboration with researchers from Hospital Universitario Reina Sofia (23)

2023

  1. Optimization of the molecular diagnosis of the acute hepatitis E virus infection

    Microbial Biotechnology, Vol. 16, Núm. 6, pp. 1325-1332

  2. Remdesivir plus dexamethasone is associated to improvement in the clinical outcome of COVID-19 hospitalized patients regardless of their vaccination status

    Medicina Clinica, Vol. 161, Núm. 4, pp. 139-146

  3. Role of vaccination and anti-SARS-CoV-2 antibodies in the clinical outcome of hospitalized COVID-19 patients

    Medicina Clinica, Vol. 160, Núm. 11, pp. 476-483

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019

    HIV Medicine, Vol. 23, Núm. 7, pp. 705-716

  3. Moderate to Intense Physical Activity Is Associated with Improved Clinical, CD4/CD8 Ratio, and Immune Activation Status in HIV-Infected Patients on ART

    Open Forum Infectious Diseases, Vol. 9, Núm. 3

2021

  1. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated with the Severity of Coronavirus Disease 2019

    Journal of Infectious Diseases, Vol. 224, Núm. 2, pp. 229-240

2020

  1. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 1, pp. 28-32

  2. Ribavirin as a first treatment approach for hepatitis e virus infection in transplant recipient patients

    Microorganisms, Vol. 8, Núm. 1

  3. Sample pooling for SARS-CoV-2 RT-PCR screening

    Clinical Microbiology and Infection, Vol. 26, Núm. 12, pp. 1687.e1-1687.e5

2019

  1. Increasing importance of european lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain

    Eurosurveillance, Vol. 24, Núm. 9

  2. T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors

    Antiviral Research, Vol. 162, pp. 163-170

2018

  1. Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients

    Medicine (United States), Vol. 97, Núm. 38

2017

  1. Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study

    HIV Medicine, Vol. 18, Núm. 7, pp. 482-489

  2. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

  3. The N-terminal pro brain natriuretic peptide is the best predictor of mortality during hospitalization in patients with low risk of sepsis-related organ failure

    Medicina Clinica, Vol. 149, Núm. 5, pp. 189-195

2016

  1. Human immunodeficiency virus/hepatitis C virus coinfection in Spain: Prevalence and patient characteristics

    Open Forum Infectious Diseases, Vol. 3, Núm. 2

  2. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  3. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

2010

  1. Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain

    Journal of Clinical Microbiology, Vol. 48, Núm. 11, pp. 4200-4206